Skip to main content
Clinical Trials/NCT00334919
NCT00334919
Completed
Phase 2

Randomized Clinical Trial of the Naturopathic Anti-Inflammatory Diet

National University of Natural Medicine1 site in 1 country30 target enrollmentMay 2006

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
National University of Natural Medicine
Enrollment
30
Locations
1
Primary Endpoint
Cytokines
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to determine if the naturopathic Anti-Inflammatory Diet results in reduced inflammation and a better response by the immune system when compared to a standard diabetic diet based on the current American Diabetes Association guidelines.

Detailed Description

This study will test the effects of two different diets on the immune system and inflammation in diabetes and pre-diabetes. These diets are the "Anti-Inflammatory Diet" (AI Diet) used by many naturopathic doctors and a standard diabetic diet based on the American Diabetes Association recommendations (ADA Diet). The AI diet excludes wheat, dairy products, eggs, red meat, caffeine, alcohol, peanuts and certain fruits and vegetables. The ADA diet includes most foods but controls the amount of each of the food groups. Naturopathic physicians often use healthful diets to treat diseases but many of these diets have not been compared to usual medical diet treatments. We will be looking at blood markers that show how the immune system responds to the different diets. We are expecting that the AI diet will result in less inflammation and a better response by the immune system than the ADA diet. We will also be looking at levels of blood lipids and glucose to see any effects on these risk factors.

Registry
clinicaltrials.gov
Start Date
May 2006
End Date
December 2007
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • BMI: 25-45 kg/m2
  • Age 18-75 yrs
  • Diagnosed with type 2 diabetes or pre-diabetes
  • At risk for type 2 diabetes. Must meet 2 of the following 3 criteria: BMI 30-45 kg/m2, age 50 or older, and/or family history of type 2 diabetes
  • Fasting blood glucose of 100-200 mg/dl
  • Provide informed consent

Exclusion Criteria

  • Current major debilitating mental or physical illness that would interfere with participation (as determined by the participant's medical history)
  • Taking diabetic medication other than sulfonylurea
  • Taking Gymnema silvestra (a naturopathic diabetes treatment)
  • Taking medications that have anti-inflammatory affects (lipid lowering agents, NSAIDS, COX 2 inhibitors, aspirin, HRT, oral contraceptives, testosterone, seizure medications)
  • Taking weight loss medications
  • Severe renal, hepatic, or heart disease
  • Triglycerides \>500 mg/dL
  • Pregnancy or lactation
  • Current excessive use of alcohol
  • Current/recent chronic use of recreational drugs

Outcomes

Primary Outcomes

Cytokines

Time Frame: 13 weeks

Secondary Outcomes

  • Glucose(113 weeks)
  • Weight(13 weeks)
  • Lipids(13 weeks)

Study Sites (1)

Loading locations...

Similar Trials